Migratory properties of GFP+ T cells in TC-1 tumors
. | No. of tumors . | No. of regions . | No. of tracks . | Mean velocitya . | Confinement ratioa . | Displacementa . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sample | n | n | n | μm min−1 | no unit | μm | ||||||
| Nonvaccinated day 2 | 2 | 5 | 50 | 5.7 (4.1,8.1) | 0.18 (0.08,0.34) | 10.6 (5.3,29.8) | ||||||
| Nonvaccinated day 3 | 3 | 5 | 50 | 5.9 (4.4,7.8) | 0.17 (0.10,0.31) | 9.5 (6.5,22.5) | ||||||
| Nonvaccinated day 4 | 2 | 5 | 50 | 5.6 (3.8,7.7) | 0.14 (0.09,0.25) | 13.2 (5.2,18.6) | ||||||
| Vaccinated day 2 | 4 | 9 | 90 | 6.0 (4.9,7.9) | 0.19 (0.11,0.37) | 13.0 (6.5,34.0) | ||||||
| Vaccinated day 3 | 3 | 11 | 110 | 7.5 (5.6,9.3) | 0.29 (0.16,0.49) | 26.9 (13.3,49.1) | ||||||
| Vaccinated day 4 | 2 | 9 | 90 | 9.8 (7.6, 12.0) | 0.49 (0.22,0.63) | 62.1 (21.6,85.9) | ||||||
| Samples comparedb | ||||||||||||
| Vaccinated days 2/3 | P < 0.001 | P < 0.05 | P < 0.01 | |||||||||
| Vaccinated days 3/4 | P < 0.001 | P < 0.01 | P < 0.001 | |||||||||
| Vaccinated days 2/4 | P < 0.001 | P < 0.001 | P < 0.001 | |||||||||
| Nonvaccinated days 2/ 3 | P > 0.05 | P > 0.05 | P > 0.05 | |||||||||
| Nonvaccinated days 3/4 | P > 0.05 | P > 0.05 | P > 0.05 | |||||||||
| Nonvaccinated days 2/4 | P > 0.05 | P > 0.05 | P > 0.05 | |||||||||
| Nonvaccinated day 2/vaccinated day 2 | P > 0.05 | P > 0.05 | P > 0.05 | |||||||||
| Nonvaccinated day 2/vaccinated day 4 | P < 0.001 | P < 0.001 | P < 0.001 | |||||||||
. | No. of tumors . | No. of regions . | No. of tracks . | Mean velocitya . | Confinement ratioa . | Displacementa . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sample | n | n | n | μm min−1 | no unit | μm | ||||||
| Nonvaccinated day 2 | 2 | 5 | 50 | 5.7 (4.1,8.1) | 0.18 (0.08,0.34) | 10.6 (5.3,29.8) | ||||||
| Nonvaccinated day 3 | 3 | 5 | 50 | 5.9 (4.4,7.8) | 0.17 (0.10,0.31) | 9.5 (6.5,22.5) | ||||||
| Nonvaccinated day 4 | 2 | 5 | 50 | 5.6 (3.8,7.7) | 0.14 (0.09,0.25) | 13.2 (5.2,18.6) | ||||||
| Vaccinated day 2 | 4 | 9 | 90 | 6.0 (4.9,7.9) | 0.19 (0.11,0.37) | 13.0 (6.5,34.0) | ||||||
| Vaccinated day 3 | 3 | 11 | 110 | 7.5 (5.6,9.3) | 0.29 (0.16,0.49) | 26.9 (13.3,49.1) | ||||||
| Vaccinated day 4 | 2 | 9 | 90 | 9.8 (7.6, 12.0) | 0.49 (0.22,0.63) | 62.1 (21.6,85.9) | ||||||
| Samples comparedb | ||||||||||||
| Vaccinated days 2/3 | P < 0.001 | P < 0.05 | P < 0.01 | |||||||||
| Vaccinated days 3/4 | P < 0.001 | P < 0.01 | P < 0.001 | |||||||||
| Vaccinated days 2/4 | P < 0.001 | P < 0.001 | P < 0.001 | |||||||||
| Nonvaccinated days 2/ 3 | P > 0.05 | P > 0.05 | P > 0.05 | |||||||||
| Nonvaccinated days 3/4 | P > 0.05 | P > 0.05 | P > 0.05 | |||||||||
| Nonvaccinated days 2/4 | P > 0.05 | P > 0.05 | P > 0.05 | |||||||||
| Nonvaccinated day 2/vaccinated day 2 | P > 0.05 | P > 0.05 | P > 0.05 | |||||||||
| Nonvaccinated day 2/vaccinated day 4 | P < 0.001 | P < 0.001 | P < 0.001 | |||||||||